India's COVID-19 vaccination coverage has crossed 156 crore with more than 57 lakh vaccine doses administered on Saturday, the Union health ministry said.
In view of continuous spike in Coronavirus cases in Uttar Pradesh, the state government has started a campaign 'My village, my locality is 100% vaccinated'. Under this, health workers are going door-to-door to check on vaccination (Covid-19 Vaccine). Village heads, NGOs are also contributing in this campaign. INDIA TV's special show 'Ye Public Hai Sab Jaanti Hai' reached Deoria and interacted with doctors, CMOs, health workers as well as people regarding this campaign.
According to reports, Bharat Biotech has proposed that its nasal vaccine can be used as booster dose for those who have already been inoculated with Covaxin or Covishield vaccines against coronavirus.
There are many who are confused if they should get vaccinated if the woman is pregnant or a couple is planning to conceive. There are many questions about the COVID-19 vaccine and fertility, here's what medical experts have to say.
Eight Omicron cases have so far been reported in Uttar Pradesh and of the patients, three have recovered and the others are in home isolation, the chief minister said.
The registration for all potential beneficiaries on the Co-WIN portal had begun from January 1, 2022. They can also avail walk-in registration at the vaccination centres from today.
"It's a hat-trick! It's now 3rd vaccine developed in India!", Health Minister Mandaviya said.
Covaxin is now the second vaccine cleared for use for children in India.
The cumulative doses administered in the country so far under the nationwide COVID-19 vaccination drive has exceeded 139.70 crore.
Rahul Gandhi said that going by the current vaccination rate, 42 per cent of the population will be vaccinated by December 2021.
FDA has given emergency authorization for 16 and 17 year-olds to get a third dose of the vaccine made by Pfizer.
A booster dose of COVID-19 vaccines, administered months after primary vaccination, is expected to augment immunity against the virus, including neutralizing capacity against the 'variants of concern'.
Almost 20 countries have, so far, reported cases of Omicron, and the EU has tightened travel restrictions since it was first reported earlier this month.
The B.1.1.529 strain of COVID-19, or 'Omicron' was first reported in South Africa on November 24.
The Delhi High Court asked why should Covid-19 vaccines which are set to expire not be given as booster shots to those fully vaccinated.
On November 3, the World Health Organisation (WHO) had granted emergency use approval for Covaxin.
Covishield, the India-manufactured Oxford-AstraZeneca COVID-19 vaccine, was added to the UK's approved list last month.
ZyCoV-D is the first DNA plasmid vaccine in the world for human use, developed indigenously by the company against the COVID-19 virus, Zydus Cadila said.
Bharat Biotech's Covaxin and AstraZeneca and Serum Institute's Covishield are the two widely used vaccines in India.
Moderna said that FDA needs more time to complete its assessment and the review may not be completed until January 2022.
Top News
Latest News
